F-star Therapeutics, Inc.: F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., May 17, 2021 (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, today announces first quarter 2021 financial results and provides a corporate update.
Strengthens balance sheet with successful closing of
$65 million public offering of common stock and;
Received $9.2 million in net proceeds under its at-the-market equity offering program
LAG-3 and PD-(L)1 co-targeting validation with LAG-3 validated in late-stage clinical trial as third checkpoint inhibitor pathway
FS118
FS222 presentation at AACR on the importance of tuning both affinity and avidity for differentiation
Horizon Technology Finance Corporation Leads $30 Million Venture Loan Facility for TemperPack
News provided by
Share this article
Share this article
FARMINGTON, Conn., May 10, 2021 /PRNewswire/ Horizon Technology Finance Corporation (NASDAQ: HRZN) ( Horizon ), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today it led a $30 million venture loan facility to TemperPack Technologies, Inc. ( TemperPack ), of which Horizon funded $7.5 million of the intial $15 million draw and an investment vehicle managed by Horizon Technology Finance Management LLC, Horizon s advisor, funded $7.5 million.
$0.30
When declaring distributions, the Horizon board of directors reviews estimates of taxable income available for distribution, which may differ from consolidated net income under generally accepted accounting principles due to (i) changes in unrealized appreciation and depreciation, (ii) temporary and permanent differences in income and expense recognition, and (iii) the amount of spillover income carried over from a given year for distribution in the following year. The final determination of taxable income for each tax year, as well as the tax attributes for distributions in such tax year, will be made after the close of the tax year.
Horizon maintains a Dividend Reinvestment Plan ( DRIP ) that provides for the reinvestment of distributions on behalf of its stockholders, unless a stockholder has elected to receive distributions in cash. As a result, if Horizon declares a distribution, its stockholders who have not opted out of the DRIP by the distribution record date will
Horizon Technology Finance Announces First Quarter 2021 Financial Results
- Net Investment Income per Share of $0.31; NAV per Share of $11.07 -
- Debt Portfolio Yield of 15.2% -
- Declares Monthly Distributions of $0.10 per Share through September -
- Grew Portfolio Quarter-over-Quarter to $380 Million -
News provided by
Share this article
Share this article
FARMINGTON, Conn., April 27, 2021 /PRNewswire/ Horizon Technology Finance Corporation (NASDAQ: HRZN) ( Horizon or the Company ), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the first quarter ended March 31, 2021.